Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test

Article summary

Vivos Therapeutics has acquired an 11% equity interest in SOD Sciences and a 50% co-ownership interest in a pseudohypoxia early-warning test, aiming to expand its patient reach.